Cargando…

Screening of peripheral arterial disease in primary health care

BACKGROUND AND PURPOSE: The screening tool for diagnosing lower extremity arterial disease is the assessment of the ankle-brachial index (ABI), which is widely used in general practice. However, resting ABI can easily produce a false negative result. In light of this, our goal was to determine the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tóth-Vajna, Zsombor, Tóth-Vajna, Gergely, Gombos, Zsuzsanna, Szilágyi, Brigitta, Járai, Zoltán, Berczeli, Márton, Sótonyi, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709362/
https://www.ncbi.nlm.nih.gov/pubmed/31686829
http://dx.doi.org/10.2147/VHRM.S208302
_version_ 1783446193085349888
author Tóth-Vajna, Zsombor
Tóth-Vajna, Gergely
Gombos, Zsuzsanna
Szilágyi, Brigitta
Járai, Zoltán
Berczeli, Márton
Sótonyi, Péter
author_facet Tóth-Vajna, Zsombor
Tóth-Vajna, Gergely
Gombos, Zsuzsanna
Szilágyi, Brigitta
Járai, Zoltán
Berczeli, Márton
Sótonyi, Péter
author_sort Tóth-Vajna, Zsombor
collection PubMed
description BACKGROUND AND PURPOSE: The screening tool for diagnosing lower extremity arterial disease is the assessment of the ankle-brachial index (ABI), which is widely used in general practice. However, resting ABI can easily produce a false negative result. In light of this, our goal was to determine the proportion of definitive diagnoses (peripheral arterial disease [PAD] confirmed or refuted) among patients screened in general practice, and the rate of cases in which the need for further specialized examination is necessary, with special attention to groups having non-compressible arteries and ABI negative symptomatic status. The aim of our work is to improve the efficiency of primary health care screening in PAD and reduce the extremely high domestic amputation ratio. PATIENTS AND METHODS: Eight hundred and sixteen patients were screened. We used the Edinburgh Questionnaire and recorded medical histories, major risk factors, current complaints, and medication. Physical examinations were performed, including ABI testing. RESULTS: Thirty-three percent complained about lower extremity claudication; 23% had abnormal ABI values; 13% of the patients within the normal ABI range had complaints of dysbasia; and 12% were in the non-compressible artery group. The ABI-negative symptomatic group’s risk factor profile showed a close similarity to the clear PAD-positive and non-compressible artery groups. CONCLUSION: The percentage of PAD could be higher than the number of patients diagnosed by ABI screening. Nearly a quarter of the population fell into the non-compressible artery and ABI-negative symptomatic groups, together defined as the “murky zone”. When screening purposely for PAD, these patients deserve special attention due to the insufficient selectivity and sensitivity of measurements. If there is high clinical suspicion of PAD in spite of normal ABI values, further assessment may be considered.
format Online
Article
Text
id pubmed-6709362
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67093622019-11-04 Screening of peripheral arterial disease in primary health care Tóth-Vajna, Zsombor Tóth-Vajna, Gergely Gombos, Zsuzsanna Szilágyi, Brigitta Járai, Zoltán Berczeli, Márton Sótonyi, Péter Vasc Health Risk Manag Original Research BACKGROUND AND PURPOSE: The screening tool for diagnosing lower extremity arterial disease is the assessment of the ankle-brachial index (ABI), which is widely used in general practice. However, resting ABI can easily produce a false negative result. In light of this, our goal was to determine the proportion of definitive diagnoses (peripheral arterial disease [PAD] confirmed or refuted) among patients screened in general practice, and the rate of cases in which the need for further specialized examination is necessary, with special attention to groups having non-compressible arteries and ABI negative symptomatic status. The aim of our work is to improve the efficiency of primary health care screening in PAD and reduce the extremely high domestic amputation ratio. PATIENTS AND METHODS: Eight hundred and sixteen patients were screened. We used the Edinburgh Questionnaire and recorded medical histories, major risk factors, current complaints, and medication. Physical examinations were performed, including ABI testing. RESULTS: Thirty-three percent complained about lower extremity claudication; 23% had abnormal ABI values; 13% of the patients within the normal ABI range had complaints of dysbasia; and 12% were in the non-compressible artery group. The ABI-negative symptomatic group’s risk factor profile showed a close similarity to the clear PAD-positive and non-compressible artery groups. CONCLUSION: The percentage of PAD could be higher than the number of patients diagnosed by ABI screening. Nearly a quarter of the population fell into the non-compressible artery and ABI-negative symptomatic groups, together defined as the “murky zone”. When screening purposely for PAD, these patients deserve special attention due to the insufficient selectivity and sensitivity of measurements. If there is high clinical suspicion of PAD in spite of normal ABI values, further assessment may be considered. Dove 2019-08-20 /pmc/articles/PMC6709362/ /pubmed/31686829 http://dx.doi.org/10.2147/VHRM.S208302 Text en © 2019 Tóth-Vajna et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tóth-Vajna, Zsombor
Tóth-Vajna, Gergely
Gombos, Zsuzsanna
Szilágyi, Brigitta
Járai, Zoltán
Berczeli, Márton
Sótonyi, Péter
Screening of peripheral arterial disease in primary health care
title Screening of peripheral arterial disease in primary health care
title_full Screening of peripheral arterial disease in primary health care
title_fullStr Screening of peripheral arterial disease in primary health care
title_full_unstemmed Screening of peripheral arterial disease in primary health care
title_short Screening of peripheral arterial disease in primary health care
title_sort screening of peripheral arterial disease in primary health care
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709362/
https://www.ncbi.nlm.nih.gov/pubmed/31686829
http://dx.doi.org/10.2147/VHRM.S208302
work_keys_str_mv AT tothvajnazsombor screeningofperipheralarterialdiseaseinprimaryhealthcare
AT tothvajnagergely screeningofperipheralarterialdiseaseinprimaryhealthcare
AT gomboszsuzsanna screeningofperipheralarterialdiseaseinprimaryhealthcare
AT szilagyibrigitta screeningofperipheralarterialdiseaseinprimaryhealthcare
AT jaraizoltan screeningofperipheralarterialdiseaseinprimaryhealthcare
AT berczelimarton screeningofperipheralarterialdiseaseinprimaryhealthcare
AT sotonyipeter screeningofperipheralarterialdiseaseinprimaryhealthcare